Indeed, CD4 + CD28- T lymphocytes from RA patients exhibit higher concentrations of the receptor activator of nuclear factor kappa-Β ligand (RANKL) than CD28+ cells [55]. The gene discussed is CD4; the disease is rheumatoid arthritis.